Legacy Community Health will offer Cabenuva, Apretude, first injectable medications for HIV treatment and HIV prevention

HOUSTON, TX (February 11, 2022) – In January 2021, the U.S. Food and Drug Administration (FDA) announced the approval of Cabenuva, the first injectable treatment for HIV treatment. In December, the FDA approved Apretude, the first injectable treatment for HIV prevention. Legacy Community Health will be offering both of these life-changing methods of treatment and prevention to help end the HIV epidemic.